Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett, Daniel A. Haber, Qingsong Liu et al.|Nature|2012Cited by 2.6k
Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Rachel Y. Ames et al.|Cancer Research|2009Cited by 98
Supplementary Figure 6 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Rachel Y. Ames et al.|Unknown|2023Cited by 0
Supplementary Figure 4 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Rachel Y. Ames et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Rachel Y. Ames et al.|Unknown|2023Cited by 0